Literature DB >> 11728873

Mycobacterial persistence: adaptation to a changing environment.

K Höner zu Bentrup1, D G Russell.   

Abstract

Mycobacterium tuberculosis is a bacterial pathogen that can persist within an infected individual for extended periods of time without causing overt, clinical disease, in a state normally referred to as latent or chronic tuberculosis. Although the replicative state of the bacterium during this period is a matter of some conjecture, recent developments have indicated that the bacterium requires the regulated expression of a set of genes and metabolic pathways to maintain a persistent infection in an immunocompetent host. The characterization of these gene products and their role in bacterial metabolism and physiology is starting to provide insights into the mechanisms that M. tuberculosis has evolved to adopt its highly successful mode of pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728873     DOI: 10.1016/s0966-842x(01)02238-7

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  65 in total

1.  Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.

Authors:  Calvin Boon; Thomas Dick
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

2.  Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

Authors:  Leander Grode; Peter Seiler; Sven Baumann; Jürgen Hess; Volker Brinkmann; Ali Nasser Eddine; Peggy Mann; Christian Goosmann; Silke Bandermann; Debbie Smith; Gregory J Bancroft; Jean-Marc Reyrat; Dick van Soolingen; Bärbel Raupach; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

3.  Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling.

Authors:  Adel M Talaat; Sarah K Ward; Chia-Wei Wu; Elizabeth Rondon; Christine Tavano; John P Bannantine; Rick Lyons; Stephen A Johnston
Journal:  J Bacteriol       Date:  2007-03-23       Impact factor: 3.490

4.  Noncognate Mycobacterium tuberculosis toxin-antitoxins can physically and functionally interact.

Authors:  Ling Zhu; Jared D Sharp; Hiroshi Kobayashi; Nancy A Woychik; Masayori Inouye
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

5.  Carbon flux rerouting during Mycobacterium tuberculosis growth arrest.

Authors:  Lanbo Shi; Charles D Sohaskey; Carmen Pheiffer; Carmen Pfeiffer; Pratik Datta; Michael Parks; Johnjoe McFadden; Robert J North; Maria L Gennaro
Journal:  Mol Microbiol       Date:  2010-10-06       Impact factor: 3.501

6.  In vivo adaptation of the Wayne model of latent tuberculosis.

Authors:  Lisa Woolhiser; Marcela Henao Tamayo; Baolin Wang; Veronica Gruppo; John T Belisle; Anne J Lenaerts; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

7.  Construction and evaluation of luciferase reporter phages for the detection of active and non-replicating tubercle bacilli.

Authors:  Azger Dusthackeer; Vanaja Kumar; Selvakumar Subbian; Gomathi Sivaramakrishnan; Guofang Zhu; Balaji Subramanyam; Sameer Hassan; Selvakumar Nagamaiah; John Chan; Narayanan Paranji Rama
Journal:  J Microbiol Methods       Date:  2008-01-19       Impact factor: 2.363

Review 8.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

9.  Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.

Authors:  Atul T Manvar; Raghuvir R S Pissurlenkar; Vijay R Virsodia; Kuldip D Upadhyay; Dinesh R Manvar; Arun K Mishra; Hrishikesh D Acharya; Alpesh R Parecha; Chintan D Dholakia; Anamik K Shah; Evans C Coutinho
Journal:  Mol Divers       Date:  2009-06-24       Impact factor: 2.943

10.  SWR mice are highly susceptible to pulmonary infection with Mycobacterium tuberculosis.

Authors:  Oliver C Turner; Robert G Keefe; Isamu Sugawara; Hiroyuki Yamada; Ian M Orme
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.